— Know what they know.
Not Investment Advice
Also trades as: NAN.AX (ASX) · $vol 2M

NNCSF OTC

Nanosonics Limited
1W: +1.0% 1M: +5.7% 3M: -20.0% YTD: -29.7% 1Y: -28.4% 3Y: -39.5% 5Y: -64.4%
$2.04
+0.02 (+0.79%)
 
Weekly Expected Move ±2.4%
$2 $2 $2 $2 $2
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 55 · $608.6M mcap · 255M float · 0.0002% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$203M +2.1% ▲
5Y CAGR: +14.8%
Gross Profit
$148M -4.7% ▼
5Y CAGR: +14.7%
Operating Income
$15M +67.7% ▲
5Y CAGR: +12.3%
Net Income
$18M -13.9% ▼
5Y CAGR: +15.7%
EPS (Diluted)
$0.06 -13.9% ▼
5Y CAGR: +15.4%
EBITDA
$24M -25.6% ▼
5Y CAGR: +13.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$120M$168M$170M$199M$203M
YoY Growth+17.6%+39.9%+1.5%+17.0%+2.1%
Cost of Revenue$34M$42M$38M$43M$55M
Gross Profit$86M$126M$132M$156M$148M
Gross Margin72.0%75.0%77.9%78.2%73.0%
R&D Expenses$21M$27M$33M$35M$29M
SG&A Expenses$68M$85M$93M$104M$104M
Operating Expenses$85M$108M$123M$147M$133M
Operating Income$792K$18M$9M$9M$15M
Operating Margin0.7%10.7%5.4%4.5%7.4%
Interest Expense$557K$771K$1M$1M$2M
Income Before Tax$2M$22M$13M$22M$20M
Tax Expense-$2M$2M$14K$2M$2M
Net Income$4M$20M$13M$21M$18M
Net Margin3.1%11.9%7.6%10.4%8.8%
EPS (Diluted)$0.01$0.06$0.04$0.07$0.06
EBITDA$7M$30M$16M$32M$24M
Shares Outstanding306M306M309M309M309M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms